Community Pharmacy England News

- 29TH JANUARY 2026
- 0 COMMENTS
MHRA Drug Safety Update: GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists: strengthened warnings
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a Drug Safety Alert regarding Glucagon-Like Peptide-1 (GLP-1) receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists. The product information for all GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists (dulaglutide, exenatide, liraglutide, semaglutide and tirzepatide) has been further updated to highlight the potential
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 29TH JANUARY 2026
- 0 COMMENTS
January 2026 Price Concessions 3rd Update
The Department of Health and Social Care (DHSC) has today (29/01/2026) confirmed the following list of price concessions for January 2026: Drug Pack size Price concession Aspirin 75mg tablets 28 £2.95 Chloramphenicol 0.5% eye drops 10 £2.75 Cimetidine 400mg tablets 60 £5.58 Co-codamol 30mg/500mg capsules 100 £5.68 Diclofenac sodium 50mg gastro-resistant tablets 28 £6.86 Glycerol
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 29TH JANUARY 2026
- 0 COMMENTS
NHSBSA ‘Hints & Tips’ – Issue 62
The NHS Business Services Authority (NHSBSA) produces a quarterly newsletter called “Hints & Tips for dispensing contractors”. The latest edition (Issue 62) contains some useful information and advice on: New address for end of month batch submissions Pharmacy Quality Scheme: Declaration window opens in Manage Your Service on 2 February 2026 Pharmacy Quality Scheme: Antimicrobial
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 29TH JANUARY 2026
- 0 COMMENTS
January 2026 reimbursement prices for Omeprazole Rosemont Pharmaceutical Ltd products
Community Pharmacy England has seen a large number of products with increases to their list prices on 1 January 2026. Following the price change mechanism rules, price changes for generic products up to and including the 8th of the month take effect for prescriptions dispensed in that same month. Any price changes after the 8th
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 28TH JANUARY 2026
- 0 COMMENTS
From Crisis to Recovery: CPE joins forces with primary care bodies to fight for a secure financial future
Yesterday, Community Pharmacy England joined with the British Dental Association, British Medical Association, Optometric Fees Negotiating Committee and the Association for Primary Care Audiology Providers, to host the “From Crisis to Recovery” The Future of Primary Care parliamentary event. MPs had the opportunity to learn more about primary care services and the professionals who provide
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 28TH JANUARY 2026
- 0 COMMENTS
Drug Tariff Watch – February 2026
The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 February 2026. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 28TH JANUARY 2026
- 0 COMMENTS
MHRA Class 4 Medicines Defect Notification: Arixtra solution for injection pre-filled syringes (Viatris Products Ltd)
MHRA Class 4 Medicines Defect Notification: Arixtra solution for injection pre-filled syringes (Viatris Products Ltd) Drug alert number: EL(26)A/04 Date issued: 28 January 2026 Viatris has received reports of brown discolouration and blockage in the needle of pre-filled syringes of Arixtra. This quality defect is related to oxidation of the syringe needle. DMRC reference number:DMRC-38220370 Marketing
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 28TH JANUARY 2026
- 0 COMMENTS
Medicine Supply Notification: Oxybutynin (Kentera® ) 3.9mg/24hours transdermal patches
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Oxybutynin (Kentera®) 3.9mg/24hours transdermal patches. MSN/2026/004 Tier 2 – Medium impact Date of issue: 28 January 2026 Oxybutynin (Kentera®) 3.9mg/24hours transdermal patches are out of stock until late-February 2026. Oxybutynin 5mg and 10mg modified-release tablets remain available and can support increased
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 27TH JANUARY 2026
- 0 COMMENTS
FSA recall: Aptamil First Infant Formula (Nutricia Ltd)
Date issued: 24 January 2026 FSA Ref: FSA-PRIN-03-2026 Danone is recalling Aptamil First Infant Formula because cereulide toxin has been found in the product. Affected Products Pharmacy teams should review their stock for the following product and batch code: Product Batch code Expiry Aptamil First Infant Formula (800 g) 31-10-2026 31 October 2026 Brief description of
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News
- 27TH JANUARY 2026
- 0 COMMENTS
MHRA Class 4 Medicines Defect Notification: Ocumont Eye Ointment 1% w/w Blumont Pharma Limited
MHRA Class 4 Medicines Defect Notification: Ocumont Eye Ointment 1% w/w Blumont Pharma Limited Drug alert number: EL(26)A/03 Date issued: 27 January 2026 Blumont Pharma Limited is reporting to the MHRA regarding the absence of Braille on the outer carton of one batch of Ocumont Eye Ointment 1% w/w (POM). It was identified that the Braille
Read more
- Middlesex Pharmaceutical Group
- Community Pharmacy England News

MHRA Drug Safety Update: GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists: strengthened warnings

January 2026 Price Concessions 3rd Update

NHSBSA ‘Hints & Tips’ – Issue 62

January 2026 reimbursement prices for Omeprazole Rosemont Pharmaceutical Ltd products

From Crisis to Recovery: CPE joins forces with primary care bodies to fight for a secure financial future

Drug Tariff Watch – February 2026

MHRA Class 4 Medicines Defect Notification: Arixtra solution for injection pre-filled syringes (Viatris Products Ltd)

Medicine Supply Notification: Oxybutynin (Kentera® ) 3.9mg/24hours transdermal patches

FSA recall: Aptamil First Infant Formula (Nutricia Ltd)

MHRA Class 4 Medicines Defect Notification: Ocumont Eye Ointment 1% w/w Blumont Pharma Limited

Get in Touch

Working together with key healthcare stakeholders, local councils and other healthcare organisations as necessary to ensure that the provision of pharmaceutical services continues to be an integral part of Health and Social Care